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Background: 99mTc pertechnetate is a well-known anion, used for clinical imaging of thyroid function. This
gamma emitter is transported by the sodium iodide symporter but is not incorporated into thyroglobulin.
Scintigraphy using 99mTc pertechnetate or 123iodide represents a powerful tool for the study of sodium iodide
symporter activity in different organs of living animal models. However, in many studies that have been
performed in mice, the thyroid could not be distinguished from the salivary glands. In this work, we have
evaluated the use of a clinically dedicated single-photon emission computed tomography (SPECT) camera for
thyroid imaging and assessed what improvements are necessary for the development of this technique.
Methods: SPECT of the mouse neck region, with pinhole collimation and geometric calibration, was used for the
individual measurement of 99mTc pertechnetate uptake in the thyroid and the salivary glands. Uptake in the
stomach was studied by planar whole-body imaging. Uptake kinetics and biodistribution studies were per-
formed by sequential imaging.
Results: This work has shown that thyroid imaging in living mice can be performed with a SPECT camera
originally built for clinical use. Our experiments indicate that 99mTc pertechnetate uptake is faster in the thyroid
than in the salivary glands and the stomach. The decrease in 99mTc pertechnetate uptake after injection of iodide
or perchlorate as competitive inhibitors was also studied. The resulting rate decreases were faster in the thyroid
than in the salivary glands or the stomach.
Conclusions: We have shown that a clinically dedicated SPECT camera can be used for thyroid imaging. In our
experiments, SPECT imaging allowed the analysis of 99mTc pertechnetate accumulation in individual organs and
revealed differences in uptake kinetics.
Introduction
Thyroid hormone production is a multistep process.The sodium iodide symporter (NIS), located in the baso-
lateral membrane of the thyrocyte, accumulates iodide from
the blood stream into the cells (1). Iodide then diffuses through
the apical membrane and is incorporated into organic mole-
cules, the thyroglobulins. These iodinated organic molecules
are phagocytozed and hydrolyzed into triiodothyronine and
thyroxine hormones, which are released into the blood stream.
NIS is not only found in the thyroid but is also expressed in
the stomach and the salivary glands (2), where it mediates
iodide accumulation. This process may be part of the host
defense to microbe-containing food contaminants.
During the period 1940–1960, radioactive iodide was used in
animal experiments (mostly rats) and proved to be useful for the
understanding of thyroid function and regulation. Subse-
quently, thyrocyte regulation was studied in in vitro experi-
ments on primary cultures and cell lines derived from thyroid
cells. However, animal experiments are still required for a better
knowledge of thyroid function and regulation. This is of par-
ticular interest since the development of genetically modified
mice, which represent powerful tools for such investigations.
For several decades, thyroid scintigraphy has been a well-
established technique for the diagnosis of thyroid pathologies,
but it has not been often used in animal experiments. Radio-
active 123iodide or 131iodide is used in recording the uptake of
free iodide and incorporated iodine. Several gamma emitters
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are substrates of NIS and are actively accumulated in the thy-
roid. One of these, 99mTc pertechnetate (99mTcO4), is trans-
ported by NIS but it is not incorporated into thyroglobulin (TG)
and, therefore, allows the specific study of uptake capacity.
For mouse imaging, resolution is an important issue, to
distinguish the different organs that are capable of iodide
accumulation. Some of these organs are very small. For ex-
ample, the size of a mouse thyroid lobe is approximately
1 mm0.3 mm. In addition, organs that accumulate radioac-
tive 99mTc pertechnetate can be very close to each other, that is,
the salivary glands and the thyroid. Consequently, radio-
active 99mTc pertechnetate uptake into these two organs may
be superimposed in the same image. It is therefore mandatory
to use tomography (single-photon emission computed tomo-
graphy [SPECT]) with improved spatial resolution.
Large rotating clinical cameras are a low-cost alternative to
dedicated microSPECT systems for small animal imaging.
However, these large rotating cameras are subject to me-
chanical irregularities, which may have deleterious effects on
spatial resolution because of the magnifying effect of pinhole
collimation. Earlier work using pinhole SPECT for small ani-
mal imaging was based on simple calibration methods that
only estimated a few parameters, such as the center of rota-
tion, the focal length, and the radius of rotation (3). More
accurate calibration techniques have been developed and
submillimetric spatial resolution has been reported by several
groups using different types of single and multiple pinhole
collimators (4,5) and slit-slat collimators (6).
A new calibration method has been proposed recently (7).
This method refines an initial parametric calibration (8,9) by
applying to each position of the camera a rigid body trans-
formation that is determined to improve the fit between the
measured and the calculated projections of the calibration
sources. A stable estimate of this transformation can be ob-
tained with only three calibration sources by linearizing the
equations around the position estimated by the initial para-
metric calibration.
In this study, this new method was used for imaging the
thyroid in mice using 99mTc pertechnetate. We analyzed the
spatial distribution of 99mTc pertechnetate uptake and its
dynamics in the thyroid, the salivary glands, and the stomach.
We also studied 99mTc pertechnetate discharge following ex-
cess administration of perchlorate and iodide.
Methods
Animals and study protocol
Male, wild-type mice (C57 BL6=6J) were purchased from
Charles River (L’arbresle, France). At the time of the experi-
ments, the mice were between 6 and 8 weeks old (25–30 g).
Animals were fed a standard diet. The study protocol was
approved by the Committee for Animal Studies and the Na-
tional Institutes of Health Principles of Animal Laboratory
Care (NIH publication 86–23, revised 1995).
About 250–300 MBq of 99mTc pertechnetate (99mTcO4) was
injected intraperitoneally. After 10 minutes, animals were
anesthetized and kept asleep during the complete imaging
protocol using isoflurane gas (1.5 vol% in air). Pinhole SPECT
imaging of the neck (nSPECT) began 20 minutes after 99mTcO4
injection (nSPECT 1, Fig. 1) and was followed by whole-body
planar imaging (wbPLANAR). Animals were then injected
intraperitoneally with sodium chloride (2 mg NaCl), sodium
perchlorate (2 mg NaClO4), or sodium iodide (2 mg NaI).
Three animals were used for each experimental condition.
Pinhole SPECT of the neck followed by wbPLANAR was
repeated 10 minutes (nSPECT 2, wbPLANAR 2) and 40
minutes later (nSPECT 3, wbPLANAR 3).
Neck SPECT imaging
SPECT projection images of the mouse neck were obtained
using a large field-of-view rotating gamma camera (Sopha
DSX; Sopha Medical System, General Electric, Buc, France)
equipped with a pinhole collimator with a 1 mm aperture. The
acquisition parameters were 64 projections over 3608, circular
orbit, and a 21 mm radius of rotation. The photopeak window
was set at 126–154 keV. Data were collected in 128128 pixel
matrix with an acquisition zoom 2, resulting in a 2.26 mm
detector pixel size. The total acquisition time was 20 minutes
(15 seconds for each projection).
The tomographic images were reconstructed by an iterative
reconstruction algorithm based on the ordered subset expecta-
tion maximization scheme using three iterations in combination
with eight subsets. The reconstruction algorithm incorporated
(i) the pinhole geometry, (ii) the collimator response and (iii) the
angular variation of the detector sensitivity (10).
The pinhole geometry was determined using the calibra-
tion method presented by Beque et al. (8,9) and recently re-
fined by Defrise et al. (7). The technique first acquired circular
orbit projection data of a three-point source phantom, which
forms a triangle with known dimensions. The phantom was
composed of three cylindrical holes, filled with 100mCi=mL
99mTc pertechnetate, of 1 mm diameter and 1 mm depth,
drilled into a 4-mm-thick plexiglas plaque. The locations of the
three sources on each projection image were then determined
using simple segmentation techniques. The focal length of the
pinhole collimator, the radius of rotation, the mechanical and
electronic shifts, as well as the tilt and the twist of the detector
were then determined for each projection by fitting iteratively
the analytically calculated locations to the measured locations
(8,9). The fit was further refined by applying a rigid body
transformation to each position of the camera, as recently
proposed by Defrise et al. (7). The collimator response was
corrected using a multiray method (11), which models the
finite dimension of the pinhole opening by calculating each
data sample as the average of seven rays in the forward
and backward projector of the reconstruction algorithm. The







FIG. 1. Study protocol. After 99mTc pertechnetate injection,
neck single-photon emission computed tomography imag-
ing (nSPECT) followed by whole-body planar imaging
(wbPLANAR) were performed three times. Animals were
then injected intraperitoneally with sodium chloride (NaCl),
sodium perchlorate (NaClO4), or sodium iodide (NaI), im-
mediately after the first total body planar imaging.
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angular variation of the sensitivity due to the pinhole colli-
mator was corrected by acquiring a 99mTc pertechnetate flood
source, which was positioned directly on the pinhole colli-
mator surface. The measured sensitivity map was incorpo-
rated into the reconstruction process. There was no correction
for partial volume, scatter, or attenuation.
The reconstructed data were stored in a 0.2-mm pixel-size
matrix and postfiltered with a three-dimensional (3D) Gauss
filter with a full-width at half maximum of 0.4 mm. Post-
reconstruction spatial resolution measured on the Ultra-Micro
Hot Spot Phantom (Data Spectrum Corporation, Chapel Hill,
NC) using these acquisition and processing parameters was
1 mm.
wbPLANAR
Planar whole-body images of the mice in the anterior view
were obtained with the pinhole opening located 10 cm from
the body surface. Data were recorded during 300 seconds into
a 128128 matrix with 2.26 mm pixel size and corrected for
the angular variation of the sensitivity of the detector using
the measured sensitivity map described earlier.
Image analysis
SPECT image viewing and quantification were performed
using AMIDE software (A Medical Image Data Examiner)
(12). Images of the three SPECT studies obtained for each
animal were analyzed side by side. 3D regions of interest
(ROIs) were automatically drawn around the thyroid and the
salivary glands of the first SPECT (nSPECT 1) by thresholding
the image of each organ at 25% of the maximum pixel value in
each organ. These ROIs were then used to measure 99mTc
pertechnetate uptake in the thyroid and the salivary glands on
the three nSPECT acquisitions, respectively. Uptake was cal-
culated as counts in the tissue divided by the injected activity
after decay correction. A pinhole SPECT acquisition of a 2-mL
syringe containing 37 MBq=mL of 99mTc pertechnetate was
performed as a reference for the conversion of injected activity
into measured counts in the image.
The planar, whole-body image was used to quantify the
uptake of 99mTc pertechnetate in the stomach. A ROI was
drawn on the stomach using a threshold of 25% of the maxi-
mal activity. For each of the three acquisitions, counts in the
stomach were normalized to the total body activity measured
on the first acquisition (wbPLANAR 1) after decay correction.
Statistical analysis
Results are presented as mean standard error of the mean.
A two-tail paired t-test was used to determine the significance
of changes in 99mTc pertechnetate uptake in organs.
Results
Spatial distribution of 99mTc pertechnetate
uptake in living mice
According to our study protocol (Fig. 1), whole-body im-
ages of mice in the anterior view were first obtained 40–45
minutes (5 minutes acquisition) after intraperitoneal injection
of 99mTc pertechnetate (Fig. 2A). Activities were predomi-
nantly located in the stomach, the bladder, and the neck re-
gion, but in these whole-body planar images the thyroid
could not be clearly distinguished from the large salivary
glands. Resolution of the thyroid in planar imaging was sig-
nificantly improved if the pinhole was positioned as close as
possible to the thyroid. This can be illustrated by the first
projection image (15 seconds=acquisition) of each SPECT ac-
quisition, which corresponds to anterior views (Fig. 2B–D).
The thyroid was then clearly observed with the acquisition
that was performed almost immediately after 99mTc pertech-
netate injection (20 minutes). The distinction between the
thyroid and the salivary glands decreased progressively
with time (nSPECT 1–3), because of increased accumulation
in the salivary glands (compare Fig. 2B, C, and D). This ef-
fect was more important with whole-body images (wbPLA
NAR 1–3) (data not illustrated; only wbPLANAR 1 is shown
in Fig. 2A).
In contrast, using tomographic images of the neck
(nSPECT), easier distinction of the thyroid from the salivary
glands was expected, especially using our refined calibration
method. The two thyroid lobes were clearly visualized in
coronal (Fig. 2E), sagittal (Fig. 2F), and transverse (Fig. 2G)
slices from nSPECT 1 (20–40 minutes).
Dynamics of 99mTc pertechnetate uptake
From each nSPECT image, 3D ROIs were drawn around
the thyroid and the salivary glands and 99mTcO4 uptake was
calculated for each organ. The 99mTc pertechnetate uptake in
the thyroid averaged 1.87% 0.67% of the initial dose (% ID)
20–40 minutes after 99mTc pertechnetate injection (nSPECT 1),
1.97% 0.74% ID 60–80 minutes after 99mTc pertechnetate
injection (nSPECT 2), and 1.86% 0.75% ID 90–110 minutes
after 99mTc pertechnetate injection (nSPECT 3) (Fig. 3A). This
result indicates that 99mTcO4 uptake in the thyroid quickly
reaches a maximal value. As illustrated in Figure 3B, where
the values are expressed as a percentage of the final 99mTc
pertechnetate uptake, no increase was observed between
nSPECT 1 and nSPECT 2 or 3 (Fig. 3B).
In contrast, 99mTc pertechnetate uptake in the salivary
glands increased slightly, but significantly ( p< 0.05), from
13.65% 5.1% ID 20–40 minutes after 99mTc pertechnetate
injection (nSPECT 1) to 18% 6.5% ID 60–80 minutes after
99mTc pertechnetate injection (nSPECT 2) and further in-
creased to 20.8% 7.3% ID 90–110 minutes after 99mTc per-
technetate injection (nSPECT 3) (Fig. 3). These results indicate
that the maximal value in 99mTc pertechnetate uptake is at-
tained more gradually in the salivary glands (Fig. 3B).
The uptake of 99mTc pertechnetate in the stomach, measu-
red on the whole-body planar images obtained immediately
after SPECT imaging, averaged 30.6% 8.5% ID 45–50 min-
utes after 99mTc pertechnetate injection (wbPLANAR 1). Ac-
tivity increased to 34% 6.6% ID 80–85 minutes after 99mTc
pertechnetate injection (wbPLANAR 2) and to 37% 7% ID
110–115 minutes after 99mTc pertechnetate injection (wbPLA-
NAR 3) ( p< 0.05, Fig. 3). This indicates that 99mTc pertech-
netate uptake is slower in the stomach than in the thyroid.
Effect of sodium perchlorate and sodium iodide
on 99mTc pertechnetate uptake in the thyroid,
the salivary glands, and the stomach
We also analyzed the effects of competitive inhibitors on
99mTc pertechnetate uptake. Two inhibitors were used—
perchlorate (ClO4
) and iodide (I)—which are both NIS
substrates and are known to block 99mTc pertechnetate
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uptake. As illustrated in Figure 4, a rapid inhibition of 99mTc
pertechnetate uptake in the thyroid and, to a lesser extent, in
the salivary glands was observed in nSPECT 2 and 3. For
the thyroid, 99mTc pertechnetate uptake decreased from the
value obtained in nSPECT 1 (20–40 minutes) (set to 100%)
to 35% 12% (nSPECT 2, 60–80 minutes) and 22% 9%
(nSPECT 3, 90–110 minutes) after NaClO4 injection or to
31% 7% (nSPECT 2, 60–80 minutes) and 21% 5%
(nSPECT 3, 90–110 minutes) after NaI injection (Fig. 5, upper
panel). For the salivary glands, 99mTc pertechnetate uptake
decreased from the value obtained in nSPECT 1 (20–40
minutes) (set to 100%) to 64% 8% (nSPECT 2, 60–80 min-
utes) and 45% 8% (nSPECT 3, 90–110 minutes) after Na-
ClO4 injection or to 89% 4% (nSPECT 2, 60–80 minutes)
and 75% 4% (nSPECT 3, 90–110 minutes) after NaI injec-
tion (Fig. 5, middle panel). The reason for the discrepancy
between NaClO4 and NaI is unknown. For the stomach,
99mTc pertechnetate uptake decreased from the value ob-
tained in wbPLANAR 1 (40–45 minutes) (set to 100%) to
73% 10% (wbPLANAR 2, 80–85 minutes) and 61% 13%
(wbPLANAR 3, 110–115 minutes) after NaClO4 injection or
to 77% 11% (wbPLANAR 2, 80–85 minutes) and
70% 16% (wbPLANAR 3, 110–115 minutes) after NaI in-
jection (Fig. 5, lower panel).
Discussion
Our study indicates that NIS activity in different mouse
organs can be studied in vivo using SPECT imaging and 99mTc
pertechnetate. Tomography was required to distinguish
between 99mTc pertechnetate uptake in the thyroid and its
uptake in the salivary glands. 3D visualization, at high reso-
lution, of the thyroid was obtained with a SPECT camera
originally dedicated to clinical applications. One millimeter
spatial resolution was achieved with a custom-made pinhole
collimator after geometric calibration of the camera. 99mTc
pertechnetate uptake into the thyroid, the salivary glands, and
the stomach of mice was analyzed. We found that 99mTc
pertechnetate accumulation was slower in the salivary glands
and the stomach compared with the thyroid. We also found
that 99mTc pertechnetate efflux after iodide or perchlorate in-
jection was slower in the salivary glands and the stomach
compared with the thyroid. As the masses of the salivary
gland and the stomach are larger than the mass of the thyroid,
the percentages of the injected dose that accumulated are
higher.
As has been well established in both humans and mice,
three main tissue types accumulate 99mTc pertechnetate: the
thyroid, the stomach, and the salivary glands. High NIS gene
expression levels have been detected in these three organs
(13,14), and this has been corroborated with immunohisto-
chemical analyses (2,15). With respect to 99mTc pertechnetate
uptake, it is important to point out that, besides NIS expres-
sion, tissue organization may play an important role. In the
thyroid, the stomach, and the salivary glands, high NIS ex-
pression levels were found in epithelial cell-delimiting com-
partments: thyroid colloid, gastric lumen, and salivary acini
and duct lumens, respectively. Consequently, 99mTc pertech-
netate uptake in these organs is not only related to the ra-
diotracer accumulation in NIS-expressing cells but also to the
radiotracer accumulation into the corresponding compart-
ments. We assume that the slower uptake and efflux rates in
FIG. 2. Left panel: Whole
body imaging (A) of a normal
mouse was obtained in ante-
rior view with the pinhole at
10 cm from the body, 40–45
minutes after 99mTc pertech-
netate injection. The image
was calibrated to the maximal
value in the thyroid. Middle
panel: Neck anterior planar
imaging (30 seconds acquisi-
tion) was obtained with the
pinhole at 21 mm from the
neck, 20 minutes (B), 60 min-
utes (C), and 90 minutes (D)
after 99m Tc pertechnetate in-
jection (T, thyroid; SG, sali-
vary glands; S, stomach; B,
bladder). Images were cali-
brated to the maximal value
of the dynamic series. Right
panel: Coronal (E), sagittal
(F), and transverse (G) slices
of the thyroid (T) and the
salivary glands (SG) obtained
with pinhole SPECT in a
control mouse, 20–40 minutes
after 99mTc pertechnetate in-
jection. Images were cali-
brated to the maximal value
of the tomographic volume.
522 FRANKEN ET AL.
the salivary gland and the stomach are linked to compart-
ments that are proportionally larger. These differences in the
kinetics are independent of the mass of the tissue. If we
compare the percentage of the injected dose in each organ, this
is related to the mass of the organ, but also to several other
parameters, such as (i) the capacity of the NIS-expressing cells
to mediate an iodide accumulation that results from dissimilar
NIS expression in the tissues; (ii) the diffusion of accumulated
iodide into intraorgan compartments (e.g., much larger in the
stomach than in the thyroid); (iii) the passive diffusion of the
iodide through the epithelia delimiting the compartments; (iv)
the intake and output of the compartment (e.g., salivary
secretion).
As shown in this work, our SPECT imaging procedure
can distinguish between 99mTc pertechnetate uptake in the
thyroid and the salivary glands. Many reports have de-
scribed scintigraphic analyses of radioactive NIS substrates
(123iodide, 125iodide, or 131iodide, 99mTc pertechnetate,
211astatine, or 188Re perrhenate) in rodents. Most of these
experiments were performed with a nontomographic gam-
ma camera. Zuckier et al. reported an interesting and de-
tailed ex vivo kinetic analysis of the tissue distribution of
123iodide, 99mTc pertechnetate, and 188Re perrhenate by di-
rectly counting the accumulated radioactivity after organ
removal (16). This analysis clearly showed the uptake ac-
tivity of the salivary glands. These authors also studied the
tissue distribution of the isotopes using in vivo imaging. It
seems that the radiotracer detected in the neck region was
attributed to thyroid uptake without considering the sali-
vary glands. In other studies that did not focus on thyroid
uptake, the authors have also considered radioactive accu-
mulation in the mouse neck region to correspond to thyroid
uptake [see examples with 99mTc pertechnetate (17) or
211astatine (18)].
In other studies, the salivary glands were not correctly
localized on the in vivo gamma images. Isotope accumu-
lation in the region of the animal’s muzzle was related to
the salivary glands (19,20). Using SPECT imaging, Cho
et al. showed that signals obtained in this region could
rather be attributed to isotope accumulation in the nasal
mucosa (21).
This problem does not occur in rats because rat salivary
glands do not accumulate iodide (22) and probably do not
express NIS. Consequently, radioactive NIS substrate uptake
in the rat neck region can be associated exclusively with




























































































FIG. 3. Comparison of 99mTc pertechnetate uptake dy-
namics in the thyroid, the salivary glands, and the stomach.
The values were calculated from nSPECT (for the thyroid
and the salivary glands) or whole-body imaging (for the
stomach). The values are shown as a percentage of the in-
jected activity (A) or as a percentage of the final activity in
each organ (B), calculated from nSPECT 3 or wbPLANAR 3.
In (A), the time of each measurement corresponds to the
middle of the acquisition. Each value was calculated from
three independent experiments.
FIG. 4. Effect of NaClO4 or NaI on the uptake of
99mTc
pertechnetate in the thyroid and the salivary glands. Trans-
verse slices of the thyroid and the salivary glands are shown
before (nSPECT 1) and after (nSPECT 2 and nSPECT 3) in-
jection of NaClO4 or NaI. NaCl was used as the control (left
slices). The images were calibrated to the maximal value in
the thyroid at baseline, before injections (nSPECT 1).
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Our data demonstrate that the kinetics of 99mTc per-
technetate uptake into the salivary glands and the stomach
are slower than those of uptake into the thyroid. This dif-
ference could result from a higher transport activity of
the thyroid compared with these two other tissues. In ad-
dition, the ratio between the number of NIS-expressing cells
and the volume of the apical compartment differs between
these organs. The fundamental functioning unit of the thy-
roid is the colloid-containing follicle. Colloid volume is
much smaller than the gastric lumen and, therefore, should
be more rapidly filled with isotope, although the bordering
epithelial cells may show a similar transport activity. As
mentioned earlier, 99mTc pertechnetate uptake into the sal-
ivary glands is also relatively slower. In this tissue, only
duct cells express NIS, and after uptake, the isotope then
spreads first into the ducts and finally into the acini and the
tubule system before the maximal, steady-state level of organ
uptake is reached.
We also observed that the decrease in 99mTc pertechnetate
uptake is faster in the thyroid than in the salivary glands or
the stomach after injection of an excess of iodide or per-
chlorate. Both anions are competitive inhibitors of NIS and
will block the active, NIS-mediated isotope accumulation.
Differences in the kinetics of the decrease of the 99mTc per-
technetate uptake of these organs should result from dif-
ferences in the isotope efflux rates, and again, the basic
structure of each organ may play an important role. As ex-
pected, the passive efflux of 99mTc pertechnetate from the
large gastric lumen is much slower than that from the thy-
roid’s small follicles.
To compare this work with other in vivo imaging studies
using radioactive iodide, it is important to take into account
that radioactive iodide, in contrast with other NIS substrates,
can be oxidized and bound to proteins and lipids. This in-
corporation of iodide into organic molecules is especially
active in the thyroid, where it is a key process in hormone
production. During this process, which takes place in the
colloid, iodide is rapidly bound to the hormone precursor,
thyroglobulin. Consequently, the quantity of accumulated
iodide is not only correlated to its uptake equilibrium but
rapidly corresponds to the amount of iodide that has been
bound to thyroglobulin. Thus, in the thyroid, the kinetics of
accumulated radioactivity will be different for 99mTc per-
technetate and 123iodine. Although organification of iodine
has been described for the salivary glands, the process is not
very efficient, and it can be ignored in comparison with the
efficient organification in the thyroid. The effect of iodine
organification has been illustrated by Zuckier et al. (16).
These authors found that uptake kinetics in the salivary
glands were similar for 123 iodide, 99mTc pertechnetate, and
188Re perrhenate. In the thyroid, however, the accumulation
of 123iodine increased continuously, and 19 hours after in-
jection, nearly the entire injected dose was found in this
organ. The authors also confirmed this result by in vivo
imaging.
Rocchi et al. attributed the radioactive iodide accumulation
found in the neck region of mice to the unique uptake activity
of the thyroid (25). Their approach may undoubtedly have no
major consequences on the given results. As discussed earlier,
several hours after injection of the radiotracer the portion of
the radioactivity detected in the neck region, which is due to
the uptake activity of the salivary glands, can be disregarded
(20,26).
The mouse thyroid was distinguished from the salivary
glands with a newly developed, small-animal-dedicated
SPECT camera (27). However, as reported in this work,
geometric calibration of a clinically dedicated camera with a
pinhole collimator also allows the acquisition of SPECT
images with the high resolution required for mouse imag-
ing. We have shown that such high resolution is an im-
portant issue, not only for research on the thyroid but also
for all studies using a gamma emitter as a signal for in vivo









































FIG. 5. Comparison of the effect of NaClO4 or NaI on
99mTc
pertechnetate uptake in the thyroid, the salivary glands, and
the stomach. The values were calculated from SPECT (for the
thyroid and the salivary glands) or whole-body imaging (for
the stomach). The values are shown as a percentage of the
initial activity accumulated in each organ, calculated from
nSPECT 1 or wbPLANAR 1. The time of each measurement
corresponds to the middle of the acquisition. The black ar-
rows correspond to NaClO4, NaI, or NaCl injections. Each
value was calculated from three independent experiments.
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targeting of NIS expression into any cell type using gene
therapy. This enables the targeted cells to accumulate iodide
(via NIS) and they may then selectively be destroyed using
radioiodide therapy. In addition, NIS can be used as a repor-
ter gene in scintigraphic imaging for preclinical experiments.
The use of our geometric calibration system of SPECT im-
aging will allow a more detailed and precise analysis of the
NIS-expressing cell distribution in preclinical trials.
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